Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)
Mercoledì 18 agosto 2021
circa 1 minuti di lettura
Journal and Affiliations:
Therapeutic Advances in Neurological Disorders, 18 agosto 2021
Claudio Gobbi, Neurologia, Lugano
Tags:
disease-modifying therapy
guideline
multiple sclerosis
treatment recommendation
Authors:
Claudio Gobbi